Article | September 12, 2022

How To Better Plan Your Decentralized Trial: A Review Of Lessons Learned

By Shaheen Limbada, Executive Vice President, Global Operations, Veristat, Brenda Muskat, Global Clinical Project Director, Veristat, and Amy Bossoms, Senior Project Manager, Veristat

GettyImages-1327568875-technology-clinical trials-computer-medicine-research

The focus on delivering patient-centric practices to improve clinical trial participation by reducing the burden on patients is the cornerstone of clinical research excellence. Over the last few years, there has been a shift to bring the clinical trial to the patient’s home, an evident disruption of historical clinical trial conduct practices. While adoption has not been widespread, the COVID-19 pandemic has rapidly turned this ideology into a necessary reality.

Veristat understands how challenging it is to pivot to virtual and hybrid clinical trials successfully. With multiple virtual trials running right now, the company has designed a customized virtual/hybrid trial ecosystem that satisfies regulators, sponsors and the patients’ needs.

Read this webinar presentation as panelists share lessons learned and recommendations for designing protocols that enable flexibility in your virtual trials’ conduct.

VIEW THE ARTICLE!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene